Calvin Frye for the past five years has been both a dispensary owner and an MMJ industry consultant. Frye has held several key positions in the Biotech industry for major companies like Xoma, Amgen and Baxter Biosciences, such as working his way up from Research Associate to Associate Scientist. Frye also has over a decade of experience in the cannabis industry, having worked with some of the founders of the MMJ industry (Dennis Peron and Richard Eastman) as well as many of the industry pioneering groups in Los Angeles (Americans For Safe Access and Norml). Mr. Frye has traveled the country to many (current) MMJ states on speaking engagements in order to help get MMJ legislation passed in those states. Mr. Frye has working knowledge of the regulatory issues within this industry from his experience with working with local LA government bodies and Agencies. Mr. Frye has also branded his line of cannabis genetics and trademarked the name “Cloneville” which he has attached to his genetics. In 2009, Mr. Frye consulted in the hydroponics industry where he gained extensive knowledge in the actual growing, set up and production of cannabis. Frye also owns Frye Consulting and Management Group, which handles consulting services from startup to full-scale production, including regulatory expertise. Frye earned his Bachelor of Science degree from the University of Iowa (Big Ten Conference) in Science Education. He also attended graduate college with an emphasis in General Science.